BCAL Diagnostics Limited ABN 51 142 051 223 Suite 506, Level 5, 50 Clarence Street, Sydney NSW 2000 T +61 (0) 407 983 270 W www.bcaldiagnostics.com E [email protected] 19 October 2026 RESULTS OF ANNUAL GENERAL MEETING BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “Company) is...
Results of Meeting
Filed with ASX · · 2 pages · English
Summary by 6ix AI
BCAL Diagnostics Limited reports the results of its Annual General Meeting held on a specific date, where all shareholder resolutions were passed on a poll. The announcement includes details in accordance with relevant regulations regarding voting results and proxies received. The Chair voted all discretionary votes in favor of the resolutions presented at the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
BCAL Diagnostics Limited on 6ix
In the deck
Earlier from BCAL Diagnostics
- AGM 2026 Presentation
- BREASTESTplus Research Presented at Lipidomic Conference
- GSS: Response to Media Speculation & BCAL letter to GSS
- Letter to Genetic Signatures Ltd Shareholders
- Investor Presentation - Transforming Cancer Detection
Later from BCAL Diagnostics
- BCAL Welcomes Dr John Melki's Appointment to GSS Board
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics